Key Finding
Electroacupuncture significantly improved oocyte maturation rates and fertilization rates while reducing granulosa cell apoptosis in women undergoing IVF treatment.
Researchers investigated whether electroacupuncture could improve success rates for women undergoing in vitro fertilization (IVF). This randomized controlled trial included 24 women participating in IVF programs, who were divided into two groups: 12 received real electroacupuncture treatment and 12 received sham (placebo) electroacupuncture. The study examined multiple factors important for IVF success, including egg maturation, fertilization rates, and cellular health markers in granulosa cells that support egg development.
The results showed significant improvements in the electroacupuncture group compared to the sham group. Women receiving real electroacupuncture had notably higher rates of mature eggs and better fertilization rates. The researchers also found that electroacupuncture reduced programmed cell death (apoptosis) in granulosa cells, which are critical for healthy egg development. Specifically, the treatment favorably altered the balance of proteins that regulate cell survival. However, the study found no significant changes in two growth factors (GDF9 and BMP15) that also play roles in egg maturation.
These findings suggest that electroacupuncture may be a beneficial complementary therapy for women undergoing IVF, particularly those concerned about egg quality and maturation. The treatment appears to work by protecting the cells that support egg development and creating a more favorable environment for fertilization. For women facing fertility challenges, this represents a potentially helpful addition to conventional IVF protocols. If you're considering acupuncture as part of your fertility treatment plan, seek a licensed acupuncturist with specialized training in reproductive health.
This randomized controlled trial (n=24) evaluated electroacupuncture's effects on IVF outcomes. Subjects were randomized to verum-EA (n=12) or sham-EA (n=12) groups during controlled ovarian stimulation. Researchers assessed oocyte maturation, fertilization rates, granulosa cell apoptosis index (Bax/Bcl-2 ratio), and growth factors GDF9 and BMP15 using microscopy and RT-qPCR techniques.
Results demonstrated statistically significant improvements in the verum-EA group: oocyte maturation (P=0.02), fertilization rates (P=0.03), and reduced granulosa cell apoptosis index (P<0.001). Individual apoptotic markers showed significant differences in Bax expression (P=0.04) and Bcl-2 (P=0.03). No significant differences were observed in GDF9 (P=0.34) or BMP15 (P=0.47) levels.
Clinical significance: Electroacupuncture appears to enhance IVF outcomes through anti-apoptotic mechanisms in granulosa cells rather than growth factor modulation. This supports EA as an evidence-based adjunctive therapy for patients undergoing assisted reproductive technology, particularly for improving oocyte quality and fertilization potential.
Browse our directory of verified licensed practitioners near you.
Find a practitioner →📌 Three distinct BNC1 gene variants contribute to premature ovarian insufficiency through different molecular mechanisms, with each variant affecting separate biological pathways including immune regulation, antiviral responses, and reproductive development.
📌 LbGP supplementation significantly improved oocyte quality in aged mice by restoring mitochondrial function through PPAR signaling activation and remodeling the ovarian microenvironment by reducing inflammation and increasing functional granulosa cells.
📌 Copper deficiency during pregnancy causes fetal growth restriction by disrupting placental structure, impairing trophoblast cell function, and dysregulating lipid metabolism in the placenta.